Integer Holdings Corporation ITGR

126.34 0.17 0.13% as of 25 Sep
Market cap
$4.3B
P/E
34.2×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.50
Total sells 5.30
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy 1 3 — — — — — — — — — —
Sell — 1 — — — 1 — — — — — 2
Insider Ownership 0.74%

Capital & Financial Ratios

Market Cap 4,290.00
Revenue 1,843.44
Net Income 128.40
Free Cash Flow 111.98
Net Debt 1,267.80
Current Ratio 3.73
Debt/Equity 0.75
P/E ratio 34.23
P/S ratio 2.33
P/B ratio 2.50
Past 5Y EPS Growth 4.13%
This Y EPS Growth (3.85%)
Next Y EPS Growth 11.50%
Next 5Y EPS Growth 4.53%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 24 47 17 21
Receivables 231 245 346 339
Inventory 229 247 254 288
Other 86 104 113 119
618 671 770 811
2023 2024 2025 Q'26
Payables 118 101 113 112
ST’ Debt — 10 — —
Other — — — —
221 227 232 217
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 8.76% 11.54% 11.67%
Cash Flow 31.72% 1.58% 19.01%
Earnings 0.00% 5.88% 15.70%
Book Value 7.46% 6.56% 7.21%

Revenue

Mar Jun Sep Dec Year
’26 440 464 — — —
’25 437 476 468 472 1,854
’24 408 428 431 449 1,717
’23 379 400 397 380 1,556
’22 311 350 343 328 1,331
’21 290 312 306 313 1,221
’20 328 240 236 269 1,073
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 25 60 — — —
’25 31 44 66 55 196
’24 23 47 72 63 205
’23 6 56 62 56 180
’22 18 19 28 52 116
’21 36 32 49 39 157
’20 32 46 32 71 181
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 1 37 — — —
’25 6 25 46 28 105
’24 (6) 16 45 44 100
’23 (19) 23 37 18 60
’22 8 7 7 20 42
’21 29 22 37 16 104
’20 14 33 23 59 130
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 0.48 0.69 — — —
’25 (0.66) 1.04 1.11 1.38 2.89
’24 0.59 0.88 0.99 0.90 3.36
’23 0.39 0.71 0.81 0.78 2.69
’22 0.34 0.62 0.48 0.54 1.99
’21 0.65 0.89 0.66 0.71 2.91
’20 0.94 0.01 0.92 0.47 2.33
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

3.1
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
18.10 29.00 42.50 67.72 46.01 73.32 50.05 63.00 94.56 62.00

Analyst estimates 2026–2028

Powerpack
Low Price
47.77 55.20 90.03 92.62 99.95 101.61 88.58 100.99 142.76 146.36
High Price
9,400 9,700 8,250 8,250 7,500 9,000 10,000 10,500 11,000 11,000
Employees
0 0 0 0 0 0 0 0 0 0
Revenue/Emp
1,076 1,136 1,215 1,258 1,073 1,221 1,331 1,556 1,717 1,854
Revenue
31.40% 31.16% 29.85% 28.22% 26.62% 27.60% 25.97% 26.35% 26.74% 26.99%
Gross Margin
28 49 61 105 86 101 69 105 148 125
EBT
2.62% 4.34% 5.03% 8.36% 8.03% 8.28% 5.16% 6.77% 8.60% 6.76%
EBT Margin
6 67 168 96 77 97 66 91 120 103
Net Income
98 114 138 86 84 88 94 107 115 138
Depreciation
34.94 36.18 37.81 38.56 32.68 37.01 40.19 46.69 51.09 53.37
Revenue/Sh
0.19 2.12 5.23 2.95 2.35 2.93 2.00 2.72 3.57 2.96
Earnings/Sh
3.43 4.76 5.21 5.07 5.52 4.75 3.51 5.41 6.11 5.65
Cash Flow/Sh
(1.89) (1.49) (1.35) (1.48) (1.56) (1.61) (2.24) (3.60) (3.14) (2.62)
Capex/Sh
1.54 3.27 3.85 3.59 3.96 3.14 1.28 1.81 2.96 3.03
Free CF/Sh
23.56 28.45 33.00 35.32 38.70 41.06 42.79 45.59 48.19 50.28
Book Value/Sh
31 31 32 33 33 33 33 33 34 35
Shares
155.53 21.62 14.67 27.17 34.55 29.21 34.24 36.12 37.22 26.86
PE Ratio
0.85 1.25 2.02 2.09 2.48 2.31 1.70 2.10 2.59 1.47
PS Ratio
1.25 1.60 2.31 2.28 2.10 2.08 1.60 2.15 2.75 1.56
PB Ratio
2.41 2.64 2.76 2.72 3.12 2.98 2.39 2.72 3.16 2.12
EV/Sales
54.77 29.24 27.07 29.23 25.76 36.77 84.31 75.98 54.83 37.66
EV/FCF
106 149 167 165 181 157 116 180 205 196
Op' Cash Flow
(58) (47) (44) (48) (51) (53) (74) (120) (106) (91)
Capex
47 103 124 117 130 104 42 60 100 105
FCF
332 323 252 236 257 293 335 397 444 538
Working Cap'
1,730 1,609 926 815 731 836 933 970 1,014 1,214
Total Debt
1,678 1,572 900 801 682 818 909 947 967 1,197
Net Debt
725 893 1,060 1,152 1,271 1,355 1,417 1,519 1,619 1,747
Sh' Equity
0.21% 2.35% 6.49% 4.12% 3.27% 3.91% 2.47% 3.16% 3.98% 3.17%
ROA
2.42% 3.19% 4.96% 5.04% 3.86% 3.90% 3.03% 4.14% 5.03% 4.70%
ROIC
0.76% 8.24% 17.19% 8.71% 6.38% 7.37% 4.79% 6.17% 7.64% 6.11%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Integer Holdings Corporation peers in Medical Devices

All 149 Medical Devices stocks →

Integer Holdings Corporation (ITGR) key facts

  • Integer Holdings Corporation (ITGR) is a Medical Devices company in the Healthcare sector, listed on the New York Stock Exchange.
  • Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
  • Net income was $102.8 million, or $2.96 per share (basic), a net margin of 5.55%.
  • As of September 25, 2026, ITGR traded at $126.34, a market capitalization of $4.3 billion.
  • At that price the stock trades at 34.2× trailing-twelve-month earnings and 2.3× sales.
  • Return on equity was 6.11% and debt-to-equity 0.75.

Source: company filings (standardised) and stockrow calculations.

Integer Holdings Corporation (ITGR) Latest News

News by impact score

Fine-tune

4 Sep

5

KKR's $5.7 billion buyout of Integer Holdings Corporation (ITGR) would take the company private, directly affecting shareholder value and strategic direction. KKR's $5.7 billion acquisition fundamentally redefines Integer Holdings Corporation ownership and long-term trajectory.

10 Aug

3

Integer Holdings Q2 earnings and revenues beat estimates while margins declined. Q2 earnings beat offset by margin decline indicates moderate effects on trajectory.

6 Aug

4

KKR faces fresh valuation test following bid talks for Integer Holdings Corporation (ITGR). Potential KKR acquisition bid represents major strategic development likely to shift ITGR trajectory and investor sentiment.

5 Aug

4

KKR deal prompts analysts to lift Integer Holdings (ITGR) stock fair value as views on the company are reshaped. KKR deal triggers analyst upgrades to Integer Holdings fair value estimates, pointing to major strategic effects on company trajectory.

4 Aug

5

KKR to acquire Integer Holdings Corporation in a $5.7bn all-cash deal. Full acquisition at $5.7 billion shifts Integer Holdings to private ownership and alters its strategic trajectory.

5

KKR acquires Integer Holdings in $5.7bn all-cash deal. KKR $5.7bn acquisition transforms Integer Holdings ownership and long-term trajectory.

4

KKR bid for Integer Holdings (ITGR) alongside Q2 results leaves the stock fully valued. KKR acquisition bid signals major ownership change with significant effect on ITGR trajectory and valuation.

3 Aug

5

Integer Holdings Corporation agrees to be taken private by KKR in a $5.7 billion deal. KKR acquisition for $5.7 billion will fundamentally change Integer Holdings ownership structure and strategic direction.

5

Integer Holdings shares rose after reporting earnings above expectations and announcing a KKR buyout. KKR buyout announcement signals potential acquisition that fundamentally transforms company ownership and prospects.

5

KKR acquires Integer Holdings Corporation for $5.7 billion, taking the medical device company private. Take-private acquisition by KKR for $5.7B removes Integer from public markets and resets its ownership structure.

5

KKR agrees to buy Integer Holdings Corporation in a $5.7 billion deal. Full acquisition by KKR at $5.7 billion will fundamentally redefine Integer Holdings ownership structure and long-term trajectory.

5

KKR agrees to acquire Integer Holdings Corporation in a $5.7 billion all-cash transaction. The all-cash acquisition by KKR will delist Integer and shift it to private ownership under new control.

5

KKR is acquiring Integer Holdings Corporation in a transaction valued at approximately $5.7 billion. Acquisition by KKR for $5.7 billion will fundamentally alter Integer Holdings' ownership and strategic direction.

4

Integer Holdings reported stronger than expected Q2 CY2026 results. Earnings beat can lift near-term valuation and sentiment.

3

Integer Holdings (ITGR) Q2 earnings matched estimates on revenue and EPS while key operating metrics such as margins and segment results showed year-over-year changes. Q2 earnings versus estimates and metric details can shift near-term investor sentiment and valuation for ITGR.

3

Integer Holdings Corporation reported its second quarter 2026 financial results. Quarterly earnings reports can moderately influence stock performance and investor sentiment based on the disclosed financial metrics.

31 Jul

5

Integer Holdings stock surges 21% on reports of potential KKR takeover. KKR takeover would redefine Integer Holdings ownership and long-term trajectory.

4 Jun

3

Integer Holdings 2026 outlook identifies growth drivers, associated risks, and current valuation levels for ITGR. 2026 drivers and risks analysis can moderately shift investor views on ITGR trajectory.

17 May

3

Ares raises US$30b while shifting focus to private credit and Integer Holdings Corporation (ITGR). Ares capital raise and refocus creates potential financing or credit linkage that could influence ITGR operations.

3

Integer Holdings reported Q1 earnings, triggering analysis on whether investors should buy, sell or hold the stock based on financial results and outlook. Q1 earnings results moderately influence near-term stock performance and investor positioning for Integer Holdings.

1 May

4

Integer Holdings Corporation (ITGR) released Q1 earnings call highlights covering financial results, operational updates, and forward guidance. Q1 earnings call highlights detail financial performance and guidance, likely driving significant shifts in investor sentiment and market trajectory.

4

Integer Holdings Corporation released Q1 2026 earnings call summary detailing financial results, revenue growth, profitability metrics, forward guidance, and strategic initiatives in medical devices and electronics. Quarterly earnings summaries drive substantial shifts in stock price and investor outlook via reported financials and guidance.

3

Integer Holdings Corporation (ITGR) stock rose despite Q1 earnings missing estimates, driven by year-over-year revenue growth. Quarterly earnings miss was offset by revenue growth, resulting in positive stock movement but limited long-term trajectory shift.

30 Apr

4

Integer Holdings Corporation (ITGR) reported Q1 earnings, with key metrics highlighting financial performance and operational insights. Q1 earnings reports significantly shape ITGR's financial trajectory, stock valuation, and investor sentiment.

4

Integer Holdings Corporation reported first quarter 2026 financial results. Quarterly earnings reports significantly affect financial performance and investor sentiment for Integer Holdings Corporation.

4

Integer Holdings Corporation (ITGR) announces a strategic review to maximize stockholder value. Strategic review signals potential major actions like sale, merger, or restructuring that could significantly alter ITGR's trajectory and investor sentiment.

3

Integer Holdings (NYSE:ITGR) reported Q1 CY2026 sales that surprised positively by beating estimates, but the stock price dropped following the announcement. Q1 sales beat signals financial strength but stock drop reflects market concerns over guidance or profitability, yielding moderate impact.

3

Integer Holdings Corporation (ITGR) Q1 earnings missed analyst estimates. Q1 earnings miss affects financial performance and investor sentiment but is limited to one quarter.

29 Apr

3

Integer Holdings (ITGR) Q1 earnings preview forecasts revenue around $425 million and adjusted EPS of $1.25-$1.30, fueled by growth in Cardio & Vascular and Orthopedics & Spine segments, with focus on margin expansion and acquisitions amid strong medtech demand. Q1 earnings expectations could moderately affect financial performance and investor sentiment through revenue and EPS beats or misses in key medical segments.

22 Apr

4

Integer Holdings beat Q4 earnings estimates with $426M revenue and $1.52 adjusted EPS, raised 2024 guidance to $1.55-$1.60 EPS amid strong medtech demand, stock surged 10%, analysts rate buy with PT $130 citing growth in cardiac rhythm and neuromodulation. Earnings beat and raised guidance represent major positive shift in financial trajectory and investor sentiment.

stockrow.com/ITGR · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com